Published

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychedelics
Date: 2026-12-01
Source: Crossref
DOI: 10.1016/j.psyche.2026.100029
PubMed: Unavailable

Authors

Pérez Rosal Sergio R.Faber Sonya C.

Watch author

Derived topics and classifications

psilocybin Observational Study Observational Study

Citation graph

39 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1176/appi.ajp.20231063 10.1177/0269881115609019 10.1002/cpt.2487 10.1002/chem.201904363 10.3389/fpsyt.2025.1594307 10.1007/s40262-017-0540-6 10.1038/s41380-024-02786-0 10.1016/j.fshw.2013.08.001 10.1038/s41598-025-97710-z 10.1021/acschemneuro.2c00170 10.1017/s1092852922000888 10.1111/j.1360-0443.2004.00744.x

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01

Related papers

Appetite for change: How nutritional state and ventral striatal dopamine shape psilocybin effects on cognitive flexibilitybioRxiv · 2026-08-23 Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-08-14 A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of PsilocybinClinicalTrials.gov · 2026-07-17 Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorderTranslational Psychiatry · 2026-05-26 Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-21 Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-02 A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for DepressionClinicalTrials.gov · 2026-05-20 Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelPsychedelics · 2026-12-01